{
  "ptid_time": "127_S_5095_2013-05-21",
  "img_path": "/data/qiuhui/data/adni/images/127_S_5095/2013-05-21/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 74,933 mm³, 149.6% above the reference mean. With a Z-score of 3.55 (100.0th percentile), this represents profound enlargement; hippocampal volume measures 7,499 mm³, 6.6% below the reference mean. With a Z-score of -0.66 (25.5th percentile), this represents normal volume ; whole brain volume measures 1,264,110 mm³, 11.4% above the reference mean. With a Z-score of 1.62 (94.7th percentile), this represents moderate enlargement; entorhinal cortex volume measures 3,507 mm³, 17.7% below the reference mean. With a Z-score of -1.23 (11.0th percentile), this represents mild atrophy; fusiform gyrus volume measures 19,022 mm³, 4.5% below the reference mean. With a Z-score of -0.37 (35.6th percentile), this represents normal volume ; middle temporal gyrus volume measures 19,808 mm³, 11.6% below the reference mean. With a Z-score of -0.96 (16.9th percentile), this represents normal volume . ",
  "text_data": "Age is 65.9 years. Gender is Male. Education: 16 years. Handedness: Right. Race: White. Medical history: Dermatologic-Connective Tissue; Musculoskeletal; Endocrine-Metabolic; Smoking; Major Surgical Procedures. MMSE: 24.0. MoCA: 21.0. Logical Memory: 0.0. Laboratory findings: MCH: 26.00 (significant reduced); Basophils: 1.50 (significant elevated). APOEε4 alleles: 2.0. Biomarker levels: Florbetapir (AV45): 1.45 SUVR (significant elevated); Amyloid beta: 382.50 pg/mL (moderate reduced); Total tau: 319.10 pg/mL (normal ); Phosphorylated tau: 34.29 pg/mL (moderate elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The data shows significant ventricular enlargement (Z-score 3.55) and moderate whole-brain enlargement, alongside mild entorhinal cortex atrophy (Z-score -1.23). The hippocampal volume is normal, but cognitive scores (MMSE 24, MoCA 21) are below expected norms for age, with biomarker evidence of amyloid pathology (elevated AV45, moderate Aβ reduction, and elevated P-tau).  \n\n**Diagnosis:** **Dementia (likely Alzheimer’s disease)**  \n**Confidence:** **High**  \n\n(Key findings: Ventricular enlargement and entorhinal atrophy suggest neurodegeneration, while cognitive impairment and AD biomarkers strongly support dementia due to Alzheimer’s pathology.)",
  "timestamp": "2025-07-26T13:25:53.118675"
}